Found: 12
Select item for more details and to access through your institution.
Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 80, doi. 10.1159/000447118
- By:
- Publication type:
- Article
Comparison of the Therapeutic Efficacy of the Early and the Delayed Use of Vinorelbine-Based Regimens for Patients with Advanced Breast Cancer.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 71, doi. 10.1159/000448472
- By:
- Publication type:
- Article
New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 62, doi. 10.1159/000443984
- By:
- Publication type:
- Article
Characterization of Integrons and qnr Genes in Proteeae from a Teaching Hospital in China.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 12, doi. 10.1159/000445426
- By:
- Publication type:
- Article
Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 54, doi. 10.1159/000447117
- By:
- Publication type:
- Article
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 58, doi. 10.1159/000448750
- By:
- Publication type:
- Article
Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 43, doi. 10.1159/000446361
- By:
- Publication type:
- Article
Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014).
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 1, doi. 10.1159/000445022
- By:
- Publication type:
- Article
Characterization of Integrons and Sulfonamide Resistance Genes among Bacteria from Drinking Water Distribution Systems in Southwestern Nigeria.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 34, doi. 10.1159/000446150
- By:
- Publication type:
- Article
GEMOX: An Active Regimen for the Treatment of Luminal and Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 30, doi. 10.1159/000445936
- By:
- Publication type:
- Article
Hemoglobin Value Is the Most Important Factor in the Development of Hand-Foot Syndrome under the Capecitabine Regimen.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 23, doi. 10.1159/000445866
- By:
- Publication type:
- Article
Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 19, doi. 10.1159/000444518
- By:
- Publication type:
- Article